These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 31141025)
21. The usefulness of listening social media for pharmacovigilance purposes: a systematic review. Convertino I; Ferraro S; Blandizzi C; Tuccori M Expert Opin Drug Saf; 2018 Nov; 17(11):1081-1093. PubMed ID: 30285501 [TBL] [Abstract][Full Text] [Related]
22. Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilance. Lee I; Lee TA; Crawford SY; Kilpatrick RD; Calip GS; Jokinen JD Expert Opin Drug Saf; 2020 Oct; 19(10):1357-1366. PubMed ID: 32662668 [TBL] [Abstract][Full Text] [Related]
23. Mining heterogeneous networks with topological features constructed from patient-contributed content for pharmacovigilance. Yang CC; Yang H Artif Intell Med; 2018 Aug; 90():42-52. PubMed ID: 30093253 [TBL] [Abstract][Full Text] [Related]
24. Exploring brand-name drug mentions on Twitter for pharmacovigilance. Carbonell P; Mayer MA; Bravo À Stud Health Technol Inform; 2015; 210():55-9. PubMed ID: 25991101 [TBL] [Abstract][Full Text] [Related]
25. Evaluating Twitter as a complementary data source for pharmacovigilance. Lardon J; Bellet F; Aboukhamis R; Asfari H; Souvignet J; Jaulent MC; Beyens MN; Lillo-LeLouët A; Bousquet C Expert Opin Drug Saf; 2018 Aug; 17(8):763-774. PubMed ID: 29991282 [TBL] [Abstract][Full Text] [Related]
26. Exploring Spanish health social media for detecting drug effects. Segura-Bedmar I; Martínez P; Revert R; Moreno-Schneider J BMC Med Inform Decis Mak; 2015; 15 Suppl 2(Suppl 2):S6. PubMed ID: 26100267 [TBL] [Abstract][Full Text] [Related]
27. Validation of New Signal Detection Methods for Web Query Log Data Compared to Signal Detection Algorithms Used With FAERS. Colilla S; Tov EY; Zhang L; Kurzinger ML; Tcherny-Lessenot S; Penfornis C; Jen S; Gonzalez DS; Caubel P; Welsh S; Juhaeri J Drug Saf; 2017 May; 40(5):399-408. PubMed ID: 28155198 [TBL] [Abstract][Full Text] [Related]
28. Portable automatic text classification for adverse drug reaction detection via multi-corpus training. Sarker A; Gonzalez G J Biomed Inform; 2015 Feb; 53():196-207. PubMed ID: 25451103 [TBL] [Abstract][Full Text] [Related]
29. Data mining for detecting signals of adverse drug reaction of doxycycline using the Korea adverse event reporting system database. Heo JY; Cho MK; Kim S J Dermatolog Treat; 2022 Jun; 33(4):2192-2197. PubMed ID: 34057876 [TBL] [Abstract][Full Text] [Related]
30. Ten years of pharmacovigilance in Italy: the experience of Emilia-Romagna region in the monitoring of drug's safety profile. Motola D; Melis M; Lo Bianco S; Buccellato E; Biagi C; Vaccheri A Expert Opin Drug Saf; 2014 Jul; 13(7):867-73. PubMed ID: 24809453 [TBL] [Abstract][Full Text] [Related]
31. Detection of Adverse Drug Reactions using Medical Named Entities on Twitter. MacKinlay A; Aamer H; Yepes AJ AMIA Annu Symp Proc; 2017; 2017():1215-1224. PubMed ID: 29854190 [TBL] [Abstract][Full Text] [Related]
32. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Trifirò G; Pariente A; Coloma PM; Kors JA; Polimeni G; Miremont-Salamé G; Catania MA; Salvo F; David A; Moore N; Caputi AP; Sturkenboom M; Molokhia M; Hippisley-Cox J; Acedo CD; van der Lei J; Fourrier-Reglat A; Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1176-84. PubMed ID: 19757412 [TBL] [Abstract][Full Text] [Related]
33. High-Performance Signal Detection for Adverse Drug Events using MapReduce Paradigm. Fan K; Sun X; Tao Y; Xu L; Wang C; Mao X; Peng B; Pan Y AMIA Annu Symp Proc; 2010 Nov; 2010():902-6. PubMed ID: 21347109 [TBL] [Abstract][Full Text] [Related]
34. From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources. Trifirò G; Sultana J; Bate A Drug Saf; 2018 Feb; 41(2):143-149. PubMed ID: 28840504 [TBL] [Abstract][Full Text] [Related]
35. Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance. Aagaard L; Hallgreen CE; Hansen EH Int J Obes (Lond); 2016 Nov; 40(11):1742-1747. PubMed ID: 27478924 [TBL] [Abstract][Full Text] [Related]
36. What Can Big Data Offer the Pharmacovigilance of Orphan Drugs? Price J Clin Ther; 2016 Dec; 38(12):2533-2545. PubMed ID: 27914633 [TBL] [Abstract][Full Text] [Related]
37. Automatic detection of adverse events to predict drug label changes using text and data mining techniques. Gurulingappa H; Toldo L; Rajput AM; Kors JA; Taweel A; Tayrouz Y Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1189-94. PubMed ID: 23935003 [TBL] [Abstract][Full Text] [Related]
38. Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project. Caster O; Dietrich J; Kürzinger ML; Lerch M; Maskell S; Norén GN; Tcherny-Lessenot S; Vroman B; Wisniewski A; van Stekelenborg J Drug Saf; 2018 Dec; 41(12):1355-1369. PubMed ID: 30043385 [TBL] [Abstract][Full Text] [Related]
39. Signal Detection of Imipenem Compared to Other Drugs from Korea Adverse Event Reporting System Database. Park K; Soukavong M; Kim J; Kwon KE; Jin XM; Lee J; Yang BR; Park BJ Yonsei Med J; 2017 May; 58(3):564-569. PubMed ID: 28332362 [TBL] [Abstract][Full Text] [Related]
40. Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles? Michel C; Scosyrev E; Petrin M; Schmouder R Clin Drug Investig; 2017 May; 37(5):415-422. PubMed ID: 28224371 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]